Potential Therapeutic Treatments for MPV17-Involved Diseases (G4358)

Target Name: MPV17

NCBI ID: G4358

MPV17

Potential Therapeutic Treatments for MPV17-Involved Diseases

Mitochondrial inner membrane protein MPV17 is a protein that is expressed in the mitochondria, which are organelles responsible for generating energy in the form of ATP in cells throughout the body. MPV17 is a key component of the mitochondrial inner membrane, which is a thin layer of protein and lipids that surrounds the mitochondria and facilitates their function.

Recent studies have suggested that MPV17 may have potential as a drug target or biomarker. For example, some researchers have found that inhibiting the activity of MPV17 can increase the levels of mitochondrial damage in cells, which could be useful for the development of therapeutic treatments for conditions such as Alzheimer's disease, Parkinson's disease, and cardiovascular disease.

Additionally, MPV17 has also been shown to be involved in the regulation of cellular processes that are important for brain development and function, such as the transport of oxygen and nutrients to the brain, and the production of neurotransmitters that regulate mood and behavior. This suggests that MPV17 may be a useful biomarker for the diagnosis and treatment of conditions that affect the brain, such as neurodegenerative diseases.

The structure and function of MPV17 are also of interest from a therapeutic perspective. Because it is a protein that is expressed in the mitochondria, MPV17 is thought to be involved in the regulation of mitochondrial function, which is critical for the overall health and function of cells. This suggests that MPV17 may be a useful target for drugs that are designed to modulate mitochondrial function and improve cellular health.

In conclusion, MPV17 is a protein that is expressed in the mitochondria and is thought to be involved in the regulation of mitochondrial function and cellular processes that are important for brain development and function. Its potential as a drug target or biomarker makes it an attractive target for the development of therapeutic treatments for a wide range of conditions. Further research is needed to fully understand the role of MPV17 in cellular processes and to determine its potential as a therapeutic agent.

Protein Name: Mitochondrial Inner Membrane Protein MPV17

Functions: Non-selective channel that modulates the membrane potential under normal conditions and oxidative stress, and is involved in mitochondrial homeostasis (PubMed:25861990). Involved in mitochondrial deoxynucleoside triphosphates (dNTP) pool homeostasis and mitochondrial DNA (mtDNA) maintenance (PubMed:26760297). May be involved in the regulation of reactive oxygen species metabolism and the control of oxidative phosphorylation (By similarity)

The "MPV17 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MPV17 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets